Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.Published in:Neuro-Oncology, 2023, v. 25, n. 11, p. 2001, doi. 10.1093/neuonc/noad108By:Hänsch, Lena;Peipp, Matthias;Mastall, Maximilian;Villars, Danielle;Myburgh, Renier;Silginer, Manuela;Weiss, Tobias;Gramatzki, Dorothee;Vasella, Flavio;Manz, Markus G;Weller, Michael;Roth, PatrickPublication type:Article